Myriad Genetics Ownership | Who Owns Myriad Genetics?
Myriad Genetics Ownership Summary
Myriad Genetics is owned by 96.81% institutional investors, 3.98% insiders. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Myriad Genetics shares.
MYGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Myriad Genetics | 96.81% | 3.98% | -0.78% |
| Sector | Healthcare Stocks | 50.47% | 12.28% | 37.25% |
| Industry | Diagnostics & Research Stocks | 71.57% | 9.92% | 18.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 15.15M | 18.54% | $370.59M |
| Blackrock funding, inc. /de | 10.89M | 11.62% | $62.18M |
| Vanguard group | 8.23M | 8.84% | $50.59M |
| Millennium management | 6.62M | 7.07% | $37.80M |
| Vestal point capital, lp | 5.74M | 6.12% | $32.75M |
| Glenview capital management | 5.41M | 5.80% | $24.35M |
| State street | 4.99M | 5.32% | $28.46M |
| D. e. shaw | 4.58M | 4.89% | $26.16M |
| Vanguard capital management | 4.08M | 4.36% | $23.30M |
| Acadian asset management | 3.13M | 3.34% | $17.84M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Amh equity | 400.00K | 3.60% | $2.89M |
| Pharvision advisers | 16.45K | 1.77% | $93.92K |
| Camber capital management lp | 2.00M | 1.00% | $10.62M |
| Vestal point capital, lp | 5.74M | 0.77% | $32.75M |
| Glenview capital management | 5.41M | 0.61% | $24.35M |
| Anson funds management lp | 504.38K | 0.33% | $3.65M |
| Verdad advisers, lp | 37.50K | 0.21% | $214.13K |
| State of wyoming | 107.78K | 0.06% | $615.44K |
| Alpha wealth funds | 20.00K | 0.06% | $113.00K |
| Aimz investment advisors | 36.06K | 0.06% | $205.90K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 5.74M | 0.77% | 4.09M |
| Blackrock funding, inc. /de | 10.89M | 0.00% | 2.00M |
| Sixth street partners management company | 1.74M | 0.00% | 1.74M |
| Mackenzie financial | 1.54M | 0.01% | 1.54M |
| Citadel advisors | 1.53M | 0.00% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -125.00M |
| Wellington management group llp | - | - | -4.59M |
| Earnest partners | - | - | -3.98M |
| Artisan partners limited partnership | - | - | -2.28M |
| Loomis sayles & co l p | - | - | -2.19M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 1.74M | 0.00% | 1.74M | $9.94M |
| Mackenzie financial | 1.54M | 0.01% | 1.54M | $8.77M |
| Panagora asset management | 204.85K | 0.00% | 204.85K | $1.17M |
| Zacks investment management | 81.39K | 0.00% | 81.39K | $464.75K |
| Newedge advisors | 52.38K | 0.00% | 52.38K | $299.12K |
Sold Out
| Holder | Change |
|---|---|
| Cnb bank | -1.00 |
| Jfs wealth advisors | -3.00 |
| Mendota financial group | -3.00 |
| Global financial private client | -3.00 |
| Mather group, llc. | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 199 | -2.45% | 90,708,053 | -57.39% | 96 | 0.19% | 118 | 10.28% | 58 | -15.94% |
| Mar 31, 2026 | 198 | -10.00% | 212,223,284 | 130.12% | 227 | 2.32% | 104 | -10.34% | 66 | -10.81% |
| Dec 31, 2025 | 63 | -71.49% | 13,263,036 | -85.02% | 14 | 0.16% | 30 | -74.36% | 21 | -70.42% |
| Sep 30, 2025 | 79 | -62.74% | 17,328,183 | -77.55% | 18 | 0.27% | 39 | -69.29% | 25 | -52.83% |
| Jun 30, 2025 | 218 | -5.63% | 90,330,011 | -3.80% | 97 | 0.92% | 130 | 8.33% | 52 | -32.47% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.70M | 6.09% | -224.78K |
| Vanguard Explorer Inv | 3.10M | 3.40% | -190.91K |
| State Street® SPDR® S&P® Biotech ETF | 2.97M | 3.11% | 6.82K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.88M | 3.05% | 104.80K |
| Vanguard Total Stock Mkt Idx Inv | 2.88M | 3.05% | 104.80K |
| Vanguard US Total Market Shares ETF | 2.70M | 2.96% | 2.75K |
| iShares Russell 2000 ETF | 2.36M | 2.47% | -41.95K |
| Artisan International Small-Mid Investor | 1.56M | 1.70% | -281.57K |
| Artisan Non-U.S. Small-Mid Growth Comp | 1.56M | 1.70% | -281.57K |
| EARNEST Partners Smid Cap Core Founders | 1.40M | 1.52% | -970.66K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 08, 2026 | Kumar Rashmi | - | Sell | $66.84K |
| May 14, 2026 | Bisaro Paul | - | Buy | $27.64K |
| Mar 09, 2026 | Raha Samraat S. | President and CEO | Buy | $199.84K |
| Feb 27, 2026 | Phanstiel S. Louise | - | Buy | $223.73K |
| Feb 26, 2026 | Phanstiel S. Louise | - | Buy | $242.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | 1 | 1 |
| 2026 Q1 | 4 | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
MYGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools